Yuexing Hao

Yuexing Hao

Auto-generated profile, based on publicly available information

Yuexing Hao

Cornell University, Ithaca, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 April 2023
Verified
Conference Paper
Open access
QYQian Yang
Qian Yang
YHYuexing Hao
Yuexing Hao
KQKexin Quan
Kexin Quan
SYStephen Yang
Stephen Yang
YZYiran Zhao
Yiran Zhao
FWFei Wang
Fei Wang
Clinical decision support tools (DSTs), powered by Artificial Intelligence (AI), promise to improve clinicians’ diagnostic and treatment decision-making. However, no AI model is always correct. DSTs must enable clinicians to validate each AI suggestion, convincing them to take the correct suggestions while rejecting its errors. While prior work often tried to do so by explaining AI’s inner workings or performance, we chose a different approach: We investigated how clinicians validated each other’s suggestions in practice (often by referencing scientific literature) and designed a new DST that embraces these naturalistic interactions. This design uses GPT-3 to draw literature evidence that shows the AI suggestions’ robustness and applicability (or the lack thereof). A prototyping study with clinicians from three disease areas proved this approach promising. Clinicians’ interactions with the prototype also revealed new design and research opportunities around (1) harnessing the complementary strengths of literature-based and predictive decision supports; (2) mitigating risks of de-skilling clinicians; and (3) offering low-data decision support with literature.

17 July 2025 in npj Digital Medicine
Verified
Journal Article
Open access
PDF file
YHYuexing Hao
Yuexing Hao
ZQZhiwen Qiu
Zhiwen Qiu
JHJason Holmes
Jason Holmes
CLCorinna E. Löckenhoff
Corinna E. Löckenhoff
WLWei Liu
Wei Liu
SKSaleh Kalantari
Saleh Kalantari
Large Language Models (LLMs) are increasingly used to support cancer patients and clinicians in decision-making. This systematic review investigates how LLMs are integrated into oncology and evaluated by researchers. We conducted a comprehensive search across PubMed, Web of Science, Scopus, and the ACM Digital Library through May 2024, identifying 56 studies covering 15 cancer types. The meta-analysis results suggested that LLMs were commonly used to summarize, translate, and communicate clinical information, but performance varied: the average overall accuracy was 76.2%, with average diagnostic accuracy lower at 67.4%, revealing gaps in the clinical readiness of this technology. Most evaluations relied heavily on quantitative datasets and automated methods without human graders, emphasizing “accuracy” and “appropriateness” while rarely addressing “safety”, “harm”, or “clarity”. Current limitations for LLMs in cancer decision-making, such as limited domain knowledge and dependence on human oversight, demonstrate the need for open datasets and standardized evaluations to improve reliability.


20 July 2022 in Biomedical Signal Processing and Control
Verified
Journal Article
Closed access
YFYue Fei
Yue Fei
FCFan Chen
Fan Chen
LHLifang He
Lifang He
JCJiamin Chen
Jiamin Chen
YHYuexing Hao
Yuexing Hao
HWHang Wei
Hang Wei

19 March 2023 in Health Information Science and Systems
Verified
Journal Article
Closed access
PDF file
ZCZhen Cao
Zhen Cao
GWGuoqiang Wang
Guoqiang Wang
LXLing Xu
Ling Xu
CLChaowei Li
Chaowei Li
YHYuexing Hao
Yuexing Hao
HWHang Wei
Hang Wei

18 December 2025 in npj Digital Medicine
Verified
Journal Article
Open access
YHYuexing Hao
Yuexing Hao
JHJason Holmes
Jason Holmes
MWMark R. Waddle
Mark R. Waddle
BDBrian J. Davis
Brian J. Davis
NYNathan Y. Yu
Nathan Y. Yu
WLWei Liu
Wei Liu
Cancer patients often lack timely education and personalized support due to clinician workload. This quality improvement study develops and evaluates a Large Language Model (LLM) agent, MedEduChat, which is integrated with the clinic’s electronic health records (EHR) and designed to enhance prostate cancer patient education. Fifteen non-metastatic prostate cancer patients and three clinicians recruited from the Mayo Clinic interacted with the agent between May 2024 and April 2025. Findings showed that MedEduChat has a high usability score (UMUX = 83.7/100) and improves patients’ health confidence (Health Confidence Score rose from 9.9 to 13.9). Clinicians evaluated the patient-chat interaction history and rated MedEduChat as highly correct (2.9/3), complete (2.7/3), and safe (2.7/3), with moderate personalization (2.3/3). This study highlights the potential of LLM agents to improve patient engagement and health education.